[ad_1] A medical worker collects a swab sample from a woman at a COVID-19 testing site in New York, the United States, March 29, 2022. Wang Ying | Xinhua News Agency | Getty Images At least 1 million people have been kicked off Medicaid since coverage protections implemented during the Covid-19 pandemic expired in April,…
[ad_1] [The stream is scheduled to begin at 10 a.m. ET. Please refresh the page if you don’t see a player above at that time.] A panel of independent advisors to the Food and Drug Administration is meeting Friday to make a recommendation on whether the Alzheimer’s drug Leqembi, made by Eisai and Biogen, should…
[ad_1] David Rosario remembers the late 1980s with mixed emotions. He had achieved his goal of becoming a professional dancer in New York City, but in that world he also lost many young male friends to AIDS. There were few treatment options available then for the disease that hit the gay community especially hard. “It…
[ad_1] A panel of independent advisors to the Food and Drug Administration unanimously recommended Thursday that the antibody nirsevimab be approved for use to protect infants from respiratory syncytial virus, the leading cause of hospitalization among newborns. If the FDA approves nirsevimab, the antibody would become the first medical intervention available in the U.S. that…
[ad_1] Sen. Bernie Sanders (I-VT) arrives to the U.S. Capitol Building on June 01, 2023 in Washington, DC. Anna Moneymaker | Getty Images Sen. Bernie Sanders on Wednesday called on the U.S. Health and Human Services Department to take action to ensure seniors can actually afford the expensive Alzheimer’s treatment Leqembi. Sanders, who chairs the…
[ad_1] Rep. Nanette Barragan (D-CA) speaks alongside US Department of Transportation Secretary Pete Buttigieg after a tour of the Ports of Los Angeles and Long Beach during a press conference at the Port of Long Beach on January 11, 2022 in Long Beach, California. Patrick T. Fallon | AFP | Getty Images Two Democratic lawmakers…
[ad_1] Jakub Porzycki | NurPhoto | Getty Images Global drugmaker Merck on Tuesday sued the Biden administration over Medicare‘s new powers to substantially reduce drug prices for seniors under the Inflation Reduction Act, the opening salvo in the pharmaceutical industry’s efforts to weaken the program. In a scathing complaint filed in federal court in Washington…
[ad_1] Asbe | Istock | Getty Images Moderna and Merck’s experimental cancer vaccine, used in combination with Merck‘s Keytruda, reduced the risk of the most deadly form of skin cancer spreading to other parts of the body in a clinical trial, according to the midstage trial results published Monday. Moderna and Merck’s cancer vaccine reduced…
[ad_1] Worker labors on a production line at the factory of Qilu Pharmaceutical in Haikou, Hainan province of China, February 11, 2022. Su Bikun | VCG | Getty Images The U.S. Food and Drug Administration has authorized the temporary importation of an unapproved chemotherapy drug from China in effort to ease an acute shortage of…
[ad_1] An MRI scan of an Alzheimer’s patient’s brain. GSO Images | Getty Images Medicare Part B will cover treatments for Alzheimer’s disease that receive U.S. Food and Drug Administration approval, according to the federal agency that administers the program for seniors. Anyone who has Medicare Part B and meets “eligibility criteria” will be covered…
